Linschoten, M., Geels, J., Werkhoven, E. v., Visser-Wisselaar, H., Chamuleau, M. E. D., Teske, A. J., . . . consortium, o. b. o. t. H. 1. D. –. A. Rationale and design of the HOVON 170 DLBCL-ANTICIPATE trial: Preventing anthracycline-induced cardiac dysfunction with dexrazoxane. BMC.
Chicago Style (17th ed.) CitationLinschoten, Marijke, et al. Rationale and Design of the HOVON 170 DLBCL-ANTICIPATE Trial: Preventing Anthracycline-induced Cardiac Dysfunction with Dexrazoxane. BMC.
MLA (9th ed.) CitationLinschoten, Marijke, et al. Rationale and Design of the HOVON 170 DLBCL-ANTICIPATE Trial: Preventing Anthracycline-induced Cardiac Dysfunction with Dexrazoxane. BMC.
Warning: These citations may not always be 100% accurate.